An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Cue Health Announces Appointment of Josh Ghaim, Ph.D. and Sachin Jain, M.D. to its Board of Directors
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary
Cue Health (Nasdaq: HLTH) has expanded its Board of Directors with the addition of Josh Ghaim, Ph.D., and Sachin Jain, M.D. This brings the total number of directors to seven, with five being independent. Ghaim is noted for his extensive experience in digital health and past role as Chief Technology Officer at Johnson & Johnson Consumer Health, while Jain is recognized for his leadership in healthcare innovation and current position as CEO of SCAN Group. This change aims to enhance Cue's strategic focus on making healthcare more accessible and timely.
Positive
Addition of experienced board members with expertise in health plans and innovation.
Strengthened leadership with diverse perspectives from health technology and medical backgrounds.
Negative
Potential concerns regarding continuity and experience gaps due to board changes.
SAN DIEGO--(BUSINESS WIRE)--
Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company that puts diagnostic information at the center of care, today announced that Josh Ghaim, Ph.D. and Sachin Jain, M.D. have joined its Board of Directors. Cue Health’s Board now consists of seven directors, five of whom are independent.
“On behalf of the management team and Board, I’m pleased to welcome both Josh and Sachin to the Cue team. We are excited to have vast knowledge of health plans and payors as well as the perspective of a medical doctor on Cue’s Board as we continue to pursue our vision of making healthcare more convenient, accessible, and timely by placing diagnostic information at the center of care,” said Ayub Khattak, Chairman and CEO of Cue Health.
Dr. Ghaim, who joined Cue’s Board on July 21, 2022, is the Founder and Managing Partner of Ignite Venture Studio, an innovation accelerator that builds digital health, wellness and beauty brands. Previously, he was Chief Technology Officer at Johnson & Johnson Consumer Health and a member of the Management Committee at Johnson & Johnson Consumer, Medical Devices, and the Pharma R&D leadership team. Dr. Ghaim serves on the Boards of Directors of Nonagon LTD, African Diaspora Network, Ignite Growth Brands, and Infinite Looks Inc. He holds a B.S. in chemistry from Indiana University and a Ph.D. in biochemistry and molecular biology from the University of Illinois.
Dr. Jain, who joined Cue’s Board on October 7, 2022, serves as President and CEO of SCAN Group and an adjunct professor of medicine at Stanford. Earlier in his career, he was the Chief Executive Officer of CareMore and Aspire Health, the care delivery divisions of Elevance, Inc; Chief Medical Information and Innovation Officer at Merck; an attending physician at Boston VA Medical Center; and a faculty member at Harvard's Medical and Business Schools. He has served in leadership roles in the U.S. Department of Health and Human Services. Dr. Jain is also a contributor to Forbes and serves on the Boards of Directors America’s Health Insurance Plans (AHIP), Biofourmis, and the Make-A-Wish Foundation. Dr. Jain is an Aspen Institute Health Innovator’s Fellow and holds his A.B., M.D., and MBA from Harvard University.
About Cue Health
Cue Health (Nasdaq: HLTH) is a healthcare technology company that makes it easier for individuals to access health information and places diagnostic information at the center of care. Cue Health enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. Cue Health's first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision. Outside the United States, Cue Health has received the CE mark in the European Union, Interim Order authorization from Health Canada, regulatory approval from India'sCentral Drugs Standard Control Organization, and PSAR authorization from Singapore’s Health Sciences Authority. Cue was founded in 2010 and is headquartered in San Diego. For more information, please visit www.cuehealth.com.
Who are the new members of the Cue Health Board of Directors?
Josh Ghaim, Ph.D., and Sachin Jain, M.D. are the new members.
What is the significance of the new board appointments for Cue Health?
The new appointments enhance Cue's focus on healthcare accessibility, leveraging expertise in health plans and medical innovation.
When did Josh Ghaim and Sachin Jain join the Cue Health Board?
Josh Ghaim joined on July 21, 2022, and Sachin Jain joined on October 7, 2022.
How many directors are on the Cue Health Board now?
The Cue Health Board now consists of seven directors, with five being independent.
What are the backgrounds of the new board members?
Josh Ghaim has a background in digital health and technology from Johnson & Johnson, while Sachin Jain has extensive experience in healthcare leadership and innovation.